Innate Pharma announces its turnover for the first quarter of 2011 and updates on its cash position

Innate Pharma (the “Company” - Euronext Paris: FR0010331421 – IPH) announces a turnover of 1.0 million euros for the first quarter of 2011, compared with 0.1 million euros (105 thousand euros) for the same period in 2010.

Cash, cash equivalents and current financial instruments and financial liabilities:
Cash, cash equivalents and current financial instruments of the Company amounted to 30.4 million euros as at March 31, 2011.

Annual report and Reference Document:
The French version of the 2010 Reference Document, including the Annual Financial Report,
as well as the 2010 Annual Report of the Company (in French and English), are available on its website (www.innate-pharma.com).
The English version of the 2010 Reference Document will be made available on Innate Pharma’s website in May 2011.
Hard copies of these documents are available upon request to the investor relations department of the Company.